Saturday, June 30, 2018

Zydus Cadila gets USFDA nod for blood pressure drug

Zydus Cadila gets USFDA nod for blood pressure drug Zydus Cadila today said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood pressure. The approval has been granted for the tablets in strengths of 37.5 mg/25 mg and 75 mg/50 mg.

from Moneycontrol Business News https://ift.tt/2tEouom
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FIIs ease bearish bets post-Budget, but charts warn of range-bound Nifty: Anand James

Foreign investors are reducing their negative bets on the market after the Budget. However, the market's overall sentiment remains delic...